American Pathology Partners Names Mark Lamp New Chief Executive Officer

Share Article

American Pathology Partners brings on a veteran healthcare executive as CEO to continue to drive growth and performance.

American Pathology Partners Inc., a premier provider of anatomic pathology and related testing services, today announced Mark Lamp has been named President and Chief Executive Officer. Lamp will be responsible for driving growth, expanding into new markets, and improving the clinical and operational activities throughout the organization.

Lamp brings many years of successful healthcare leadership experience to his new role at American Pathology Partners (AP2). He most recently served as CEO of American HomePatient, Inc., a leading provider of home respiratory care services. During his tenure, the company increased revenue by 10% annually and EBITDA by 18% annually. Prior to this, he was COO of AccentCare Inc., one of the nation’s largest providers of home health services. He also held senior executive positions in the healthcare software and medical imaging industries.

“AP2 excels at making the right diagnosis and doing it in a timely manner,” said Lamp. “This has always been important to the patient, and it is increasingly important to the health system. As physicians and health systems begin to think about value based care, I believe AP2 plays an increasingly important role. I look forward to extending our reach and developing partnerships in new markets.”

“NEA invested in AP2 with a vision of creating a compelling pathology platform,” said Mohamad Makhzoumi, Partner and Head of Healthcare Services and Healthcare IT investing, NEA. “AP2 has grown to the point that it is now scalable, and we believe Mark can leverage the great work that’s been done to expand our reach and fulfill our vision.”

About American Pathology Partners
Based in Nashville, American Pathology Partners (AP2) operates laboratories in Colorado, Florida, and North Carolina, serving physicians in over 26 states. Partnered with some of the nation’s leading board certified pathologists, AP2 prides itself on providing the highest quality diagnosis and unmatched service levels. To learn more, visit

About NEA
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With nearly $17 billion in cumulative committed capital since inception, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 200 portfolio company IPOs and more than 320 acquisitions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tracy Stephens
Visit website